Literature DB >> 31542271

Diffusion-Weighted MR Imaging to Evaluate Immediate Response to Irreversible Electroporation in a Rabbit VX2 Liver Tumor Model.

Su Hu1, Chong Sun2, Bin Wang3, Kang Zhou4, Liang Pan5, Junjie Shangguan6, Jia Yang6, Vahid Yaghmai7, Matteo Figini6, Zhuoli Zhang8.   

Abstract

PURPOSE: To evaluate the feasibility of diffusion-weighted imaging (DWI) in magnetic resonance imaging for quantitative measurement of responses following irreversible electroporation (IRE) in a rabbit liver tumor model.
MATERIALS AND METHODS: Twelve rabbits underwent ultrasound-guided VX2 tumor implantation in the left medial and left lateral liver lobes. The tumors in the left medial lobe were treated with IRE, whereas those in the left lateral lobe served as internal controls. DWI was performed before and immediately after IRE. Tumors were then harvested for histopathologic staining. The apparent diffusion coefficient (ADC) and change in ADC (ΔADC) were calculated based on DWI. Tumor apoptosis index (AI) was assessed by terminal deoxynucleotidyl transferase dUTP nick-end labeling. These measurements from DWI and histopathology were compared between untreated and treated tumors.
RESULTS: The ADC values, ΔADC, and AI showed statistically significant differences between treated and untreated tumors (P < .05 for all). ADC values were higher in treated tumors than in untreated tumors (1.08 × 10-3 mm2/s ± 0.15 vs 0.88 × 10-3 mm2/s ± 0.19; P = .042).
CONCLUSIONS: DWI can be used to quantitatively evaluate treatment response in liver tumors immediately after IRE. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31542271     DOI: 10.1016/j.jvir.2019.05.030

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor.

Authors:  Matteo Figini; Kang Zhou; Liang Pan; Chong Sun; Bin Wang; Su Hu; Jia Yang; Junjie Shangguan; Aydin Eresen; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Magn Reson Med       Date:  2019-12-18       Impact factor: 4.668

2.  Treatment for Liver Tumor Using Combined Transarterial Embolization and Interaarterial Transfecting HIF-1α shRNA in a Rabbit VX2 Model.

Authors:  Chuangen Guo; Cheng Wang; Jingfeng Zhang; Xiao Chen
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

Review 3.  Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma.

Authors:  Aydin Eresen; Jia Yang; Alessandro Scotti; Kejia Cai; Vahid Yaghmai; Zhuoli Zhang
Journal:  Ann Transl Med       Date:  2021-07

4.  Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound.

Authors:  Linyu Zhou; Shanyu Yin; Weilu Chai; Qiyu Zhao; Guo Tian; Danxia Xu; Tian'an Jiang
Journal:  World J Surg Oncol       Date:  2020-11-23       Impact factor: 2.754

5.  Intraprocedural Transcatheter Intraarterial Perfusion (TRIP)-MRI for Evaluation of Irreversible Electroporation Therapy Response in a Rabbit Liver Tumor Model.

Authors:  Anna J Shangguan; Kang Zhou; Jia Yang; Aydin Eresen; Bin Wang; Chong Sun; Liang Pan; Su Hu; Ali T Khan; Samdeep K Mouli; Vahid Yaghmai; Zhuoli Zhang
Journal:  Clin Exp Gastroenterol       Date:  2020-11-06

Review 6.  Recent progress in pulsed electric field ablation for liver cancer.

Authors:  Zhen-Guo Liu; Xin-Hua Chen; Zu-Jiang Yu; Jun Lv; Zhi-Gang Ren
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.